MTSR metsera.com Earnings growth forecast for next year

Corporate emblem and logo of Metsera (MTSR)

Metsera Inc (MTSR) is investing in the development of long-acting obesity injections, which impacts its financial profile. This chart of expected EPS growth for the coming year, provided by the GURU.Markets platform, shows a current value of -58.10. Capital optimization depends on FDA approval timelines and drug efficacy, as well as the recruitment of leading biochemists through stock option plans to accelerate development.

Metsera Corp (MTSR): Expected net earnings per share growth next year from 02/01/2025 to 11/29/2025

MTSR (metsera.com): analytical breakdowns and indicator data

- share price and consensus valuation forecast:
Stock Price Metsera Corp|MTSR - Analyst Consensus Forecast
- market capitalization data:
Market Capitalization Metsera|MTSR - Total Company Value
- book capitalization indicators:
Net Assets per Single Share Metsera|MTSR - Total Stockholders' Equity|Market Value to Book Value Ratio metsera.com|MTSR - Aggregate Company Assets
- debt and solvency information:
Total Debt to Capital Metsera Inc|MTSR - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity Metsera|MTSR - Company Total Debt Obligations|Debt to Book Capitalization Ratio Metsera|MTSR - Company Long-Term Liabilities|Company Short-Term Debt Metsera|Quick Ratio metsera.com
- net income and valuation ratios data:
MTSR - Company Net Income|Future Profit Metsera Inc|MTSR - Market Price to Net Income Ratio|Future Price to Earnings Metsera Inc|MTSR - Growth-Adjusted Market Cap to Net Income|EV/EBITDA Multiple Metsera|MTSR - Profit before interest, taxes and amortization|Earnings per share for the last twelve months Metsera|MTSR - Earnings per share for the trailing year|Quarterly EPS earnings growth metsera.com|MTSR - Earnings growth in current year|Expected earnings per share growth for next year Metsera Inc
Initial company analysis:MTSR, Metsera Corp
Finished products of Metsera

For Metsera Inc (MTSR), the projected net profit growth rate for n+1 reflects market expectations for EPS dynamics, accounting for the impact of inflationary costs on margins. This indicator measures expected capitalization efficiency, where the stability of active substance supplies via diversified logistics chains minimizes operational risks, directly determining the upward or downward profit trend on this chart.

Analysis of competing companies

ASND (Ascendis Pharma Inc.) - Earnings growth forecast for next year|Earnings growth forecast for next year Madrigal Corp|Earnings growth forecast for next year CORT|Net earnings per share growth forecast for next year RYTM (rhythmtx.com)|Net earnings per share growth forecast for next year Akero AKRO|MoonLake Immunotherapeutics AG (MLTX) - Expected net earnings per share growth next year|CRNX - Net earnings per share growth forecast for next year|NAMS: Net earnings per share growth forecast for next year|SLNO: Earnings growth forecast for next year|FOLD - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year 89bio|Agios (AGIO) - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year Structure Pharma (GPCR)|Expected earnings per share growth for next year MiMedx Corp MDXG|Net earnings per share growth forecast for next year Rezolute, Inc. RZLT|LXRX - Expected earnings per share growth for next year|MBX Biosciences - Earnings growth forecast for next year|Expected net earnings per share growth next year Altimmune Inc|AARD (Aardvark Therapeutics Corp) - Expected earnings per share growth for next year|SGMT: Projected earnings per share increase next year|Net earnings per share growth forecast for next year BioAge Labs, Inc.|biomeafusion.com (BMEA) - Consensus forecast of earnings per share growth for next year|Earnings growth forecast for next year QNCX|GUTS - Expected net earnings per share growth next year|Net earnings per share growth forecast for next year vTv Therapeutics VTVT|Expected earnings per share trend next year ATPC|Pluri Inc - Earnings growth forecast for next year|SYBX - Earnings growth forecast for next year|LPCN (Lipocine) - Expected earnings per share growth for next year|Matinas BioPharma Holdings - Expected earnings per share trend next year|SPRB (Spruce Biosciences, Inc.) - Earnings growth forecast for next year|Galecto Corporation (GLTO) - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year Carmell Corporation (CTCX)|lumos-pharma.com - Projected earnings per share growth rate for next year|Earnings growth forecast for next year ONVO (Organovo)|RDUS - Expected earnings per share growth for next year